November 17, 2011
CSIMC General Assembly The Central Social Insurance Medical Council (CSIMC; Chuikyo ) recommended the listing of eight active pharmaceutical ingredients (APIs)/nine products including Imusera Capsule/Gilenya Capsule (fingolimod HCl; Mitsubishi Tanabe Pharma Corporation (MTPC)/Novartis Pharma), Japan’s first oral treatment for multiple...read more